Valiant Laboratories Ltd Quarterly Results

Gross Sales

57.79

35.23

21.48

18.88

30.59

Excise Duty

0

0

0

0

0

Net Sales

57.79

35.23

21.48

18.88

30.59

Other Operating Income

0

0

0

0

0

Other Income

-2.31

1.58

3.36

2.81

2.5

Total Income

55.47

36.81

24.84

21.7

33.09

Total Expenditure

53.96

34.61

28.22

21.27

35.12

PBIDT

1.51

2.2

-3.38

0.43

-2.03

Interest

0.05

0.06

0.01

0.05

0.02

PBDT

1.46

2.14

-3.39

0.37

-2.05

Depreciation

0.52

0.52

0.52

0.53

0.52

Minority Interest Before NP

0

0

0

0

0

Tax

-0.36

0.16

0.07

0.19

-1.58

Deferred Tax

0.6

-0.88

0.76

0.16

0.25

Reported Profit After Tax

0.7

2.35

-4.74

-0.51

-1.24

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

0.7

2.35

-4.74

-0.51

-1.24

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

0.7

2.35

-4.74

-0.51

-1.24

EPS (Unit Curr.)

0.16

0.54

-1.09

-0.13

-0.33

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

43.45

43.45

43.45

43.45

43.45

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

2.61

6.24

-15.73

2.27

-6.63

PBDTM(%)

2.52

6.07

-15.78

1.95

-6.7

PATM(%)

1.21

6.67

-22.06

-2.7

-4.05